Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IV Open Label Non Comparative Trial Of IV Anidulafungin Followed By Oral Azole Therapy For The Treatment Of Candidemia And Invasive Candidiasis

NCT00496197 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00496197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00496197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IV Open Label Non Comparative Trial Of IV Anidulafungin Followed By Oral Azole Therapy For The Treatment Of Candidemia And Invasive Candidiasis
Lead sponsor
Pfizer
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2007
Completion date
June 30, 2010
Enrollment
282 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

candidiasis